1-4 of 4
John J.P. Kastelein
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial

Lawrence A. Leiter, Hwee Teoh, David Kallend, R. Scott Wright, Ulf Landmesser, Peter L.J. Wijngaard, John J.P. Kastelein, Kausik K. Ray
Journal: Diabetes Care
Diabetes Care 2019;42(1):173–176
https://doi.org/10.2337/dc18-1491
Published: 28 November 2018
View articletitled, Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial
Open the PDF for Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial in another window
Includes: Supplementary data
Journal Articles

Carriers of Loss-of-Function Mutations in ABCA1 Display Pancreatic β-Cell Dysfunction

Menno Vergeer, MD, Liam R. Brunham, MD, PHD, Joris Koetsveld, BSC, Janine K. Kruit, PHD, C. Bruce Verchere, PHD, John J.P. Kastelein, MD, PHD, Michael R. Hayden, MD, PHD, Erik S.G. Stroes, MD, PHD
Journal: Diabetes Care
Diabetes Care 2010;33(4):869–874
https://doi.org/10.2337/dc09-1562
Published: 12 January 2010
View articletitled, Carriers of Loss-of-Function Mutations in ABCA1 Display Pancreatic β-Cell Dysfunction
Open the PDF for Carriers of Loss-of-Function Mutations in ABCA1 Display Pancreatic β-Cell Dysfunction in another window
Includes: Supplementary data
Journal Articles

Metabolic Syndrome and Risk of Coronary, Cerebral, and Peripheral Vascular Disease in a Large Dutch Population With Familial Hypercholesterolemia

Jamal S. Rana, MD, PHD, Angelique C. Jansen, MD, PHD, Aeilko H. Zwinderman, PHD, Max Nieuwdorp, MD, Emily S. van Aalst-Cohen, MD, PHD, J. Wouter Jukema, MD, PHD, Mieke D. Trip, MD, PHD, John J.P. Kastelein, MD, PHD
Journal: Diabetes Care
Diabetes Care 2006;29(5):1125–1127
https://doi.org/10.2337/dc05-2530
Published: 01 May 2006
View articletitled, Metabolic Syndrome and Risk of Coronary, Cerebral, and Peripheral Vascular Disease in a Large Dutch Population With Familial Hypercholesterolemia
Open the PDF for Metabolic Syndrome and Risk of Coronary, Cerebral, and Peripheral Vascular Disease in a Large Dutch Population With Familial Hypercholesterolemia in another window
Journal Articles

Metabolic Syndrome and Risk of Restenosis in Patients Undergoing Percutaneous Coronary Intervention

Jamal S. Rana, MD, Pascalle S. Monraats, MSC, Aeilko H. Zwinderman, PHD, Moniek P.M. de Maat, PHD, John J.P. Kastelein, MD, PHD, Pieter A.F. Doevendans, MD, PHD, Robbert J. de Winter, MD, PHD, René A. Tio, MD, PHD, Rune R. Frants, PHD, Arnoud van der Laarse, PHD, Ernst E. van der Wall, MD, PHD, J. Wouter Jukema, MD, PHD
Journal: Diabetes Care
Diabetes Care 2005;28(4):873–877
https://doi.org/10.2337/diacare.28.4.873
Published: 01 April 2005
View articletitled, Metabolic Syndrome and Risk of Restenosis in Patients Undergoing Percutaneous Coronary Intervention
Open the PDF for Metabolic Syndrome and Risk of Restenosis in Patients Undergoing Percutaneous Coronary Intervention in another window